Based on the Liquidia Technologies Inc stock forecast from 6 analysts, the average analyst target price for Liquidia Technologies Inc is USD 26.92 over the next 12 months. Liquidia Technologies Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Liquidia Technologies Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Liquidia Technologies Inc’s stock price was USD 13.55. Liquidia Technologies Inc’s stock price has changed by -0.95% over the past week, -10.38% over the past month and +7.97% over the last year.
No recent analyst target price found for Liquidia Technologies Inc
No recent average analyst rating found for Liquidia Technologies Inc
Company Overview Liquidia Technologies Inc
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina. Read Less
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmon...Read More
Frequently Asked Questions About Liquidia Technologies Inc (LQDA) Stock
Based on ratings from 6 analysts Liquidia Technologies Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 12 buy, sell and hold ratings.
Unfortunately we do not have enough data on LQDA's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for LQDA is USD 26.92 over the next 12 months. The maximum analyst target price is USD 34 while the minimum anlayst target price is USD 19.
LQDA stock's Price/Earning ratio is 4.12.
Our analysis grades LQDA stock's Price / Earning ratio at F. This means that LQDA stock's Price/Earning ratio is above 44.99999999999999% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this LQDA may be fairly valued for its sector
The last closing price of LQDA's stock was USD 13.55.
The most recent market capitalization for LQDA is USD 1.15B.
Based on targets from 6 analysts, the average taret price for LQDA is projected at USD 26.92 over the next 12 months.
This means that LQDA's stock price may go up by +98.65% over the next 12 months.
We can't find any ETFs which contains Liquidia Technologies Inc's stock.
As per our most recent records Liquidia Technologies Inc has 170 Employees.
Liquidia Technologies Inc's registered address is 419 Davis Drive, Morrisville, NC, United States, 27560.
You can get more information about it from Liquidia Technologies Inc's website at https://www.liquidia.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Liquidia Technologies Inc (LQDA) Stock
Based on ratings from 6 analysts Liquidia Technologies Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 12 buy, sell and hold ratings.
Unfortunately we do not have enough data on LQDA's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for LQDA is USD 26.92 over the next 12 months. The maximum analyst target price is USD 34 while the minimum anlayst target price is USD 19.
LQDA stock's Price/Earning ratio is 4.12.
Our analysis grades LQDA stock's Price / Earning ratio at F. This means that LQDA stock's Price/Earning ratio is above 44.99999999999999% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this LQDA may be fairly valued for its sector
The last closing price of LQDA's stock was USD 13.55.
The most recent market capitalization for LQDA is USD 1.15B.
Based on targets from 6 analysts, the average taret price for LQDA is projected at USD 26.92 over the next 12 months.
This means that LQDA's stock price may go up by +98.65% over the next 12 months.
We can't find any ETFs which contains Liquidia Technologies Inc's stock.
As per our most recent records Liquidia Technologies Inc has 170 Employees.
Liquidia Technologies Inc's registered address is 419 Davis Drive, Morrisville, NC, United States, 27560.
You can get more information about it from Liquidia Technologies Inc's website at https://www.liquidia.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for LQDA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
